Rewalk Robotics Ltd
NASDAQ:LFWD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Rewalk Robotics Ltd
Cash Equivalents
Rewalk Robotics Ltd
Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Rewalk Robotics Ltd
NASDAQ:LFWD
|
Cash Equivalents
$2.2m
|
CAGR 3-Years
-68%
|
CAGR 5-Years
-36%
|
CAGR 10-Years
-19%
|
|
|
B
|
Brainsway Ltd
TASE:BWAY
|
Cash Equivalents
$70.5m
|
CAGR 3-Years
13%
|
CAGR 5-Years
35%
|
CAGR 10-Years
20%
|
|
|
Inmode Ltd
NASDAQ:INMD
|
Cash Equivalents
$302.5m
|
CAGR 3-Years
46%
|
CAGR 5-Years
34%
|
CAGR 10-Years
N/A
|
|
|
Sisram Medical Ltd
HKEX:1696
|
Cash Equivalents
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
A
|
Alpha Tau Medical Ltd
NASDAQ:DRTS
|
Cash Equivalents
$12.2m
|
CAGR 3-Years
28%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
|
S
|
Sofwave Medical Ltd
TASE:SOFW
|
Cash Equivalents
$34.8m
|
CAGR 3-Years
3%
|
CAGR 5-Years
67%
|
CAGR 10-Years
N/A
|
|
Rewalk Robotics Ltd
Glance View
ReWalk Robotics Ltd. Is a medical device company, which engages in the design, development and marketing of wearable robotic exoskeletons. The firm is engaged in designing, developing and commercializing exoskeletons that allow individuals with mobility impairments or other medical conditions the ability to stand and walk once again. The firm offers ReWalk, which is an exoskeleton that uses its tilt-sensor technology and an on-board computer and motion sensors to drive motorized legs that power movement. ReWalk designs are intended for people with paraplegia, a spinal cord injury resulting in complete or incomplete paralysis of the legs, having the use of their upper bodies and arms. The firm offers two ReWalk products: ReWalk Personal and ReWalk Rehabilitation. ReWalk Personal is designed for everyday use by paraplegic individuals at home and in their communities, and is custom fitted for each user. ReWalk Rehabilitation is designed for use by paraplegia patients in the clinical rehabilitation environment, where it provides exercise and therapy.
See Also
What is Rewalk Robotics Ltd's Cash Equivalents?
Cash Equivalents
2.2m
USD
Based on the financial report for Dec 31, 2025, Rewalk Robotics Ltd's Cash Equivalents amounts to 2.2m USD.
What is Rewalk Robotics Ltd's Cash Equivalents growth rate?
Cash Equivalents CAGR 10Y
-19%
Over the last year, the Cash Equivalents growth was -68%. The average annual Cash Equivalents growth rates for Rewalk Robotics Ltd have been -68% over the past three years , -36% over the past five years , and -19% over the past ten years .
